Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder caused due to a defect in an enzyme called glucose-6-phosphate dehydrogenase that causes red blood cells to break down prematurely.
G6PD is an enzyme that protects the red blood cells from damage and destruction by harmful and toxic compounds that form in the body under certain conditions like stress, fever, or following the ingestion of certain foods or drugs. The enzyme generates compounds that can neutralize the toxic compounds formed in the body.
It is an X-linked disorder that may be inherited from mother (usually a healthy carrier) or affected father to son or daughter. G6PD cannot be spread from one person to another. [1]
People with G6PD deficiency do not display any signs of the disease until they are exposed to certain chemicals in food or drugs whereby their RBC being broken down in excess.
Other symptoms:
It is common for babies to have jaundice (yellowing of the skin and eyes) in the first week of life, but some babies with G6PD deficiency have jaundice for longer than usual.
Blood tests may reveal low red blood cell count, increased bilirubin levels, and increased plasma hemoglobin levels. Other blood tests may confirm presence of intravascular hemolysis. However, the blood tests may be normal between the attacks.
Examination of a stained blood film under the microscope may show abnormal broken red cells (hemolytic RBCs). Special stains show denatured hemoglobin within red cells (Heinz bodies) and increased immature red cells (reticulocytes) due to formation of new red cells (erythropoiesis) by the bone marrow as compensatory response. If the abnormal cells have the appearance of a bitten piece they are termed bite cells.
The urine specimen during the attack is dark colored and positive for hemoglobin and hemosiderin
Several screening tests are available that demonstrate the decreased capacity of G6PD deficient cells to reduce dyes. The enzyme can also be directly assayed.
References: